Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹307.00
Market cap: ₹8,675 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.6×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 Jul 2026 16:51 IST NSE

Suven Life Sciences Board Meeting Outcome

Suven Life Sciences' Board approved converting warrants into 1.85 crore shares for Rs.24.88 Cr. It also reappointed an Independent Director for a 5-year term.

Value: ₹24.88 Cr

Read the filing ↗

8 Jul 2026 14:59 IST BSE

Board Meeting Outcome

Suven Life Sciences Board Meeting Outcome

SUVEN Life Sciences Limited re-appointed Mr. Vajja Sambasiva Rao as Non-Executive Independent Director for 60 months. The board meeting was held on 08‑07‑2026.

Read the filing ↗